BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 30104343)

  • 1. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome.
    Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM
    J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dravet Syndrome: A Developmental and Epileptic Encephalopathy.
    Lopez-Santiago L; Isom LL
    Epilepsy Curr; 2019 Jan; 19(1):51-53. PubMed ID: 30838929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interneuron Desynchronization Precedes Seizures in a Mouse Model of Dravet Syndrome.
    Tran CH; Vaiana M; Nakuci J; Somarowthu A; Goff KM; Goldstein N; Murthy P; Muldoon SF; Goldberg EM
    J Neurosci; 2020 Mar; 40(13):2764-2775. PubMed ID: 32102923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotides restore excitability, GABA signalling and sodium current density in a Dravet syndrome model.
    Yuan Y; Lopez-Santiago L; Denomme N; Chen C; O'Malley HA; Hodges SL; Ji S; Han Z; Christiansen A; Isom LL
    Brain; 2024 Apr; 147(4):1231-1246. PubMed ID: 37812817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ndnf Interneuron Excitability Is Spared in a Mouse Model of Dravet Syndrome.
    Liebergall SR; Goldberg EM
    J Neurosci; 2024 Apr; 44(17):. PubMed ID: 38443186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome.
    Wengert ER; Wagley PK; Strohm SM; Reza N; Wenker IC; Gaykema RP; Christiansen A; Liau G; Patel MK
    Brain Res; 2022 Jan; 1775():147743. PubMed ID: 34843701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.
    Cheah CS; Lundstrom BN; Catterall WA; Oakley JC
    J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental alterations in firing properties of hippocampal CA1 inhibitory and excitatory neurons in a mouse model of Dravet syndrome.
    Almog Y; Fadila S; Brusel M; Mavashov A; Anderson K; Rubinstein M
    Neurobiol Dis; 2021 Jan; 148():105209. PubMed ID: 33271326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome.
    Tai C; Abe Y; Westenbroek RE; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3139-48. PubMed ID: 25024183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.
    Rubinstein M; Westenbroek RE; Yu FH; Jones CJ; Scheuer T; Catterall WA
    Neurobiol Dis; 2015 Jan; 73():106-17. PubMed ID: 25281316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome.
    Goff KM; Goldberg EM
    Elife; 2019 Jul; 8():. PubMed ID: 31282864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmentally regulated impairment of parvalbumin interneuron synaptic transmission in an experimental model of Dravet syndrome.
    Kaneko K; Currin CB; Goff KM; Wengert ER; Somarowthu A; Vogels TP; Goldberg EM
    Cell Rep; 2022 Mar; 38(13):110580. PubMed ID: 35354025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective Na
    Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF
    Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
    Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW
    Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome.
    Valassina N; Brusco S; Salamone A; Serra L; Luoni M; Giannelli S; Bido S; Massimino L; Ungaro F; Mazzara PG; D'Adamo P; Lignani G; Broccoli V; Colasante G
    Nat Commun; 2022 Jan; 13(1):161. PubMed ID: 35013317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the phenotypes of Dravet syndrome by gene deletion.
    Rubinstein M; Han S; Tai C; Westenbroek RE; Hunker A; Scheuer T; Catterall WA
    Brain; 2015 Aug; 138(Pt 8):2219-33. PubMed ID: 26017580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
    Niibori Y; Lee SJ; Minassian BA; Hampson DR
    Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice.
    Mistry AM; Thompson CH; Miller AR; Vanoye CG; George AL; Kearney JA
    Neurobiol Dis; 2014 May; 65():1-11. PubMed ID: 24434335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal manipulation of the Scn1a gene reveals its essential role in adult brain function.
    Di Berardino C; Mainardi M; Brusco S; Benvenuto E; Broccoli V; Colasante G
    Brain; 2024 Apr; 147(4):1216-1230. PubMed ID: 37812819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Na
    Richards KL; Milligan CJ; Richardson RJ; Jancovski N; Grunnet M; Jacobson LH; Undheim EAB; Mobli M; Chow CY; Herzig V; Csoti A; Panyi G; Reid CA; King GF; Petrou S
    Proc Natl Acad Sci U S A; 2018 Aug; 115(34):E8077-E8085. PubMed ID: 30076230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.